{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:57:42Z","timestamp":1783011462086,"version":"3.54.6"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"vor","delay-in-days":165,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008269","name":"Laege Sofus Carl Emil Friis og Hustru Olga Doris Friis Legat","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.ctarc.2021.100426","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T06:03:59Z","timestamp":1623909839000},"page":"100426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Vibration Perception Threshold and Heart Rate Variability as methods to assess chemotherapy-induced neuropathy in women with breast cancer \u2013 a pilot study"],"prefix":"10.1016","volume":"28","author":[{"given":"Simone Diedrichsen","family":"Marstrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Buch-Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Thorbj\u00f8rn","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ctarc.2021.100426_bib0001","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in globocan 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Canc."},{"issue":"13","key":"10.1016\/j.ctarc.2021.100426_bib0002","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/cncr.31551","article-title":"Annual report to the nation on the status of cancer, part i: national cancer statistics","volume":"124","author":"Cronin","year":"2018","journal-title":"Canc."},{"key":"10.1016\/j.ctarc.2021.100426_bib0003","article-title":"NORDCAN: cancer incidence, mortality, prevalence and survival in the nordic countries [webpage]. association of the nordic cancer registries","author":"Danckert B","year":"2009","journal-title":"Danis. Canc. Socie."},{"issue":"9","key":"10.1016\/j.ctarc.2021.100426_bib0004","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1001\/jamaoncol.2015.3062","article-title":"Effectiveness of an adjuvant chemotherapy regimen for early-stage breast cancer: a systematic review and network meta-analysis","volume":"1","author":"Fujii","year":"2015","journal-title":"JAMA. Oncol."},{"issue":"9814","key":"10.1016\/j.ctarc.2021.100426_bib0005","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","article-title":"Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials","volume":"379","author":"Peto","year":"2012","journal-title":"Lance."},{"issue":"10","key":"10.1016\/j.ctarc.2021.100426_bib0006","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1200\/JCO.2005.04.0543","article-title":"Peripheral neuropathy induced by microtubule-stabilizing agents","volume":"24","author":"Lee","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2021.100426_bib0007","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1200\/JCO.1985.3.6.818","article-title":"A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer","volume":"3","author":"Jain","year":"1985","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2021.100426_bib0008","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10549-010-1278-0","article-title":"Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy","volume":"125","author":"Hershman","year":"2011","journal-title":"Breas. Canc. Res. Treat."},{"issue":"8","key":"10.1016\/j.ctarc.2021.100426_bib0009","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/annonc\/mdu186","article-title":"Final analysis of the prospective wsg-ago ec-doc versus fec phase iii trial in intermediate-risk (pn1) early breast cancer: efficacy and predictive value of ki67 expression","volume":"25","author":"Nitz","year":"2014","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2021.100426_bib0010","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx140","article-title":"Chemotherapy-Associated peripheral neuropathy in patients with early-stage breast cancer: a systematic review","volume":"110","author":"Rivera","year":"2018","journal-title":"J. Natl. Canc. Inst."},{"issue":"5","key":"10.1016\/j.ctarc.2021.100426_bib0011","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1200\/JOP.2012.000863","article-title":"Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer","volume":"9","author":"Speck","year":"2013","journal-title":"J. Oncol. Pract."},{"issue":"8","key":"10.1016\/j.ctarc.2021.100426_bib0012","first-page":"2261","article-title":"Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review","volume":"22","author":"Mols","year":"2014","journal-title":"Supp. Care Canc."},{"issue":"3","key":"10.1016\/j.ctarc.2021.100426_bib0013","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejca.2014.11.024","article-title":"Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors","volume":"51","author":"Eckhoff","year":"2015","journal-title":"Eur. J. Canc."},{"issue":"2","key":"10.1016\/j.ctarc.2021.100426_bib0014","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10549-016-3939-0","article-title":"Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk","volume":"159","author":"Bao","year":"2016","journal-title":"Breas. Canc. Res. Treat."},{"issue":"7","key":"10.1016\/j.ctarc.2021.100426_bib0015","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jamaneurol.2016.0383","article-title":"The association of chemotherapy-induced peripheral neuropathy symptoms and the risk of falling","volume":"73","author":"Kolb","year":"2016","journal-title":"JAMA. Neurol."},{"issue":"1","key":"10.1016\/j.ctarc.2021.100426_bib0016","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1212\/WNL.46.1.108","article-title":"Peripheral neuropathy secondary to docetaxel (taxotere)","volume":"46","author":"New","year":"1996","journal-title":"Neurol."},{"issue":"3","key":"10.1016\/j.ctarc.2021.100426_bib0017","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejca.2009.12.008","article-title":"Chemotherapy-Induced peripheral neurotoxicity assessment: a critical revision of the currently available tools","volume":"46","author":"Cavaletti","year":"2010","journal-title":"Eur. J. Canc."},{"issue":"6","key":"10.1016\/j.ctarc.2021.100426_bib0018","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s004010051132","article-title":"Docetaxel neuropathy: a distal axonopathy","volume":"98","author":"Fazio","year":"1999","journal-title":"Acta. Neuropathol."},{"issue":"3","key":"10.1016\/j.ctarc.2021.100426_bib0019","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jht.2011.01.001","article-title":"Progress in vibrotactile threshold evaluation techniques: a review","volume":"24","author":"Gandhi","year":"2011","journal-title":"J. Hand Ther."},{"issue":"8","key":"10.1016\/j.ctarc.2021.100426_bib0020","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","article-title":"The development of an eortc quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the qlq-cipn20","volume":"41","author":"Postma","year":"2005","journal-title":"Eur. J. Canc."},{"issue":"1","key":"10.1016\/j.ctarc.2021.100426_bib0021","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.seminoncol.2005.12.010","article-title":"Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy","volume":"33","author":"Hausheer","year":"2006","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ctarc.2021.100426_bib0022","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.psyneuen.2016.02.018","article-title":"Heart rate variability measure in breast cancer patients and survivors: a systematic review","volume":"68","author":"Arab","year":"2016","journal-title":"Psychoneuroendocrinolo."},{"issue":"1","key":"10.1016\/j.ctarc.2021.100426_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-5273(02)00057-8","article-title":"Functional assessment of heart rate variability: physiological basis and practical applications","volume":"84","author":"Pumprla","year":"2002","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.ctarc.2021.100426_bib0024","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1464-5491.2008.02433.x","article-title":"Vibrotactile sense in median and ulnar nerve innervated fingers of men with type 2 diabetes, normal or impaired glucose tolerance","volume":"25","author":"Dahlin","year":"2008","journal-title":"Diabet. Med."},{"issue":"2","key":"10.1016\/j.ctarc.2021.100426_bib0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1158\/1078-0432.CCR-0772-03","article-title":"Neurophysiological study of peripheral neuropathy after high-dose paclitaxel: lack of neuroprotective effect of amifostine","volume":"10","author":"Openshaw","year":"2004","journal-title":"Clin. Canc. Res."},{"issue":"1","key":"10.1016\/j.ctarc.2021.100426_bib0026","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11060-007-9438-8","article-title":"Peripheral neuropathy due to paclitaxel: study of the temporal relationships between the therapeutic schedule and the clinical quantitative score (qst) and comparison with neurophysiological findings","volume":"86","author":"Augusto","year":"2008","journal-title":"J. Neurooncol."},{"issue":"1","key":"10.1016\/j.ctarc.2021.100426_bib0027","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1005805907311","article-title":"Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing","volume":"35","author":"Forsyth","year":"1997","journal-title":"J. Neurooncol."},{"issue":"8","key":"10.1016\/j.ctarc.2021.100426_bib0028","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0959-8049(94)90459-6","article-title":"Paclitaxel (taxol) induces cumulative mild neurotoxicity","author":"van Gerven","year":"1994","journal-title":"Eur. J. Canc."},{"issue":"5","key":"10.1016\/j.ctarc.2021.100426_bib0029","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.CIR.93.5.1043","article-title":"Heart rate variability: standards of measurement, physiological interpretation and clinical use. task force of the european society of cardiology and the north american society of pacing and electrophysiology","volume":"93","year":"1996","journal-title":"Circulat."},{"issue":"8","key":"10.1016\/j.ctarc.2021.100426_bib0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11886-018-1010-y","article-title":"Cardiovascular autonomic dysfunction in patients with cancer","volume":"20","author":"Coumbe","year":"2018","journal-title":"Curr. Cardiol. Rep."},{"issue":"4","key":"10.1016\/j.ctarc.2021.100426_bib0031","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00001813-200204000-00012","article-title":"Docetaxel does not impair cardiac autonomic function in breast cancer patients previously treated with anthracyclines","volume":"13","author":"Ekholm","year":"2002","journal-title":"Anticanc. Drug."},{"issue":"10","key":"10.1016\/j.ctarc.2021.100426_bib0032","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1200\/JCO.2001.19.10.2746","article-title":"Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients","volume":"19","author":"Meinardi","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2021.100426_bib0033","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/hrt.81.4.419","article-title":"Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables","volume":"81","author":"Tjeerdsma","year":"1999","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ctarc.2021.100426_bib0034","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/PSY.0000000000000167","article-title":"Higher vagal activity as related to survival in patients with advanced breast cancer: an analysis of autonomic dysregulation","volume":"77","author":"Giese-Davis","year":"2015","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.ctarc.2021.100426_bib0035","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fpubh.2017.00258","article-title":"An overview of heart rate variability metrics and norms","volume":"5","author":"Shaffer","year":"2017","journal-title":"Front. Pub. Heal."},{"issue":"5","key":"10.1016\/j.ctarc.2021.100426_bib0036","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.neurobiolaging.2006.12.002","article-title":"Physiological correlates of age-related decline in vibrotactile sensitivity","volume":"29","author":"Deshpande","year":"2008","journal-title":"Neurobiol. Agi."},{"issue":"2","key":"10.1016\/j.ctarc.2021.100426_bib0037","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10549-017-4437-8","article-title":"Long-term peripheral neuropathy symptoms in breast cancer survivors","volume":"166","author":"Mustafa Ali","year":"2017","journal-title":"Breas. Canc. Res. Treat."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221001246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221001246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:24:25Z","timestamp":1762842265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294221001246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":37,"alternative-id":["S2468294221001246"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100426","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vibration Perception Threshold and Heart Rate Variability as methods to assess chemotherapy-induced neuropathy in women with breast cancer \u2013 a pilot study","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100426"}}